新經濟股拖累恆指跌幅擴至逾360點 藥明生物續跌半成 聯想創廿個月低
美聯儲及歐洲央行或繼續進取加息抗通脹,歐美主要股市延續上周五跌勢,但昨晚除納指續跌1%外,其餘跌幅均少於1%。美股期貨全面微彈,亞太股市今早普遍反彈,但升幅均少於1%。
港股繼昨天僅回吐0.7%跑贏區內結束兩連彈後,今天於期結日高開高39點或0.2%報20,062欠承接,掉頭輾轉滑落,最低見19,645,現報19,658,倒跌364或1.8%,總成交額298億元。此外,科指倒跌2.9%報4,127。
藍籌股普遍向下,尤其是藥明生物(02269.HK)續跌5.2%報67.25元;內需股吉利(00175.HK)、安踏(02020.HK)、李寧(02331.HK)及蒙牛(02319.HK)跌約2%-3%。中績多賺2倍比亞迪(01211.HK)高開逾2%,最高見270.8元無以為繼,掉頭低見259.4元,現報261.2元,倒跌1.1%。
權重股阿里(09988.HK)騰訊(00700.HK)倒跌2.4%及2.8%,報92.85元及314元;業績勝預期獲大行升價美團(03690.HK)承昨天逆升勢,今早股價高開1.4%報189.4元欠承接,掉頭倒跌3.5%報180.1元;網易(09999.HK)回吐3.2%報135.4元。
舜宇(02382.HK)、小米(01810.HK)及聯想集團(00992.HK)續跌3%-3.5%,後者最傷報6.32元創廿個月低。此外,藍籌銀行及保險股全面跌逾1%-2%,友邦(01299.HK)報75.95元,跌2%
然而,碧服(06098.HK)、東方海外(00316.HK)及龍湖(00960.HK)逆升逾1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.